Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
about
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
description
clinical trial
@en
klinisch onderzoek
@nl
name
Docetaxel, Carboplatin, and Ru ...... bination DNA Repair Deficiency
@en
type
label
Docetaxel, Carboplatin, and Ru ...... bination DNA Repair Deficiency
@en
prefLabel
Docetaxel, Carboplatin, and Ru ...... bination DNA Repair Deficiency
@en
P4844
P1476
PLATI-PARP: A Phase 2 Study of ...... bination DNA Repair Deficiency
@en
P3098
NCT03442556
P580
2018-08-24T00:00:00Z
P582
2024-05-15T00:00:00Z